Patricia S Walker

CIK 1303798 · Chief Medical Officer · last filed 2023-07-07

Patricia S Walker is a Chief Medical Officer who has filed 9 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing shows the insider was granted $37.5K of SSKN on Jul 7, 2023. Current disclosed insider exposure totals $13.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13.5K

Companies

3

Total Filings

9

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SSKN Director 89,894 $0.15 $13.5K $0 4 2023-07-07
FBRX Director $17.56 $0 4 2022-06-02
KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted Chief Medical Officer $0 1 2013-02-12

Recent Filings

9 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-07-07 SSKN Grant (A) +36,408 $37.5K EDGAR
2022-07-05 SSKN Grant (A) +50,297 $46.9K EDGAR
2022-06-02 FBRX Grant (A) $0 EDGAR
2022-04-04 SSKN Grant (A) $0 EDGAR
2022-02-24 FBRX Grant (A) $0 EDGAR
2022-02-16 SSKN Grant (A) $0 EDGAR
2021-06-01 FBRX Grant (A) $0 EDGAR
2020-06-17 FBRX Grant (A) $0 EDGAR
2013-02-12 KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted Grant (A) $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.